Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Horizon Therapeutics Publ...

    NASDAQ: HZNP · Real-Time Price · USD
    116.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Horizon Therapeutics Public Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 3.63B 3.23B
    Cost of Revenue
    		 920.2M 794.51M
    Gross Profit
    		 2.71B 2.43B
    Operating Income
    		 617.41M 543.13M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 526.94M 462.83M
    Net Income
    		 521.48M 534.49M
    Selling & General & Admin
    		 1.54B 1.45B
    Research & Development
    		 437.96M 431.99M
    Other Expenses
    		 -5.57M 1.79M
    Operating Expenses
    		 1.98B 1.88B
    Interest Expense
    		 83.71M 81.06M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 2.9B 2.67B
    Income Tax Expense
    		 5.45M -71.66M
    Shares Outstanding (Basic)
    		 229.11M 225.55M
    Shares Outstanding (Diluted)
    		 235.24M 235.68M
    EPS (Basic)
    		 2.28 2.37
    EPS (Diluted)
    		 2.22 2.27
    EBITDA
    		 1.11B 909.04M
    EBIT
    		 610.64M 543.89M
    Depreciation & Amortization
    		 497.25M 365.91M

    Add to Watchlist